These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35074409)

  • 1. The proteomic landscape of ovarian cancer cells in response to melatonin.
    Cesário RC; Gaiotte LB; Cucielo MS; Silveira HS; Delazari Dos Santos L; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
    Life Sci; 2022 Apr; 294():120352. PubMed ID: 35074409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.
    Cucielo MS; Cesário RC; Silveira HS; Gaiotte LB; Dos Santos SAA; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
    BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
    Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
    J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
    Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
    Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
    Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma.
    Chuffa LG; Alves MS; Martinez M; Camargo IC; Pinheiro PF; Domeniconi RF; Júnior LA; Martinez FE
    Endocr Relat Cancer; 2016 Feb; 23(2):65-76. PubMed ID: 26555801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.
    Muys BR; Sousa JF; Plaça JR; de Araújo LF; Sarshad AA; Anastasakis DG; Wang X; Li XL; de Molfetta GA; Ramão A; Lal A; Vidal DO; Hafner M; Silva WA
    Cancer Res; 2019 Jul; 79(13):3294-3305. PubMed ID: 31101765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
    Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
    J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms.
    Chuffa LGA; Reiter RJ; Lupi LA
    Carcinogenesis; 2017 Oct; 38(10):945-952. PubMed ID: 28575150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
    Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
    Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of NDRG2 promotes the therapeutic effect of pazopanib on ovarian cancer.
    Cui Y; Shen G; Ma L; Lv Q
    J Recept Signal Transduct Res; 2021 Dec; 41(6):546-552. PubMed ID: 33050824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells.
    Silveira HS; Cesário RC; Vígaro RA; Gaiotte LB; Cucielo MS; Guimarães F; Seiva FRF; Zuccari DAPC; Reiter RJ; Chuffa LGA
    Mol Cell Endocrinol; 2024 Oct; 592():112296. PubMed ID: 38844096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
    Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
    Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats.
    Zonta YR; Martinez M; Camargo IC; Domeniconi RF; Lupi Júnior LA; Pinheiro PF; Reiter RJ; Martinez FE; Chuffa LG
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.
    Marques JHM; Mota AL; Oliveira JG; Lacerda JZ; Stefani JP; Ferreira LC; Castro TB; Aristizábal-Pachón AF; Zuccari DAPC
    Life Sci; 2018 Sep; 208():131-138. PubMed ID: 29990486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Proteomic Profiling Reveals That Diverse Metabolic Pathways Are Influenced by Melatonin in an in Vivo Model of Ovarian Carcinoma.
    Chuffa LG; Lupi Júnior LA; Seiva FR; Martinez M; Domeniconi RF; Pinheiro PF; Dos Santos LD; Martinez FE
    J Proteome Res; 2016 Oct; 15(10):3872-3882. PubMed ID: 27604906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nucleolar spindle-associated protein 1 in human ovarian cancer.
    Zhang Y; Huang K; Cai H; Chen S; Sun D; Jiang P
    J Cell Biochem; 2020 Nov; 121(11):4397-4405. PubMed ID: 32031285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
    Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
    J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.